Classer les publications sur l'année

  • Parcours de SantĂ© et Dispositifs innovantsSantĂ© publique

    Overview of migraine care, impact of the disease, and patient experience in France through patient voices: a cross-sectional and participatory survey study

    DUBURCQ A, MOLINS M, DEBREMAEKER S, JOIE J, LOPES L, NEVORET C, BEGASSE DE DHAEM O

    The Journal of Headache and Pain volume ; 2025; 26 (76)

  • Parcours de SantĂ© et Dispositifs innovantsSantĂ© publique

    Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRIÂź) in France: An analysis of the PMSI database over five years (2019-2023)

    LE PAGE E, EMERY C, FRAVALO A, FAGNANI F, CLEMENT A

    Revue neurologique ; 2025

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA)

    TARD C, LAFORET P, DE POUVOURVILLE G, CROCHARD A, CHOLLET G, NEVORET C, BOUÉE S , SALORT‑CAMPANA E.

    Journal of Neurology ; 2024;271 (11:7239-7249)

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Epidemiology of myasthenia gravis in France: A retrospective claims database study (STAMINA).

    SALORT-CAMPANA E, LAFORET P, DE POUVOURVILLE G, CROCHARD A, CHOLLET G, NEVORET C, EMERY C, BOUEE S, TARD C.

    Rev Neurol ; 2023;

  • SantĂ© publique

    Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing.

    MARCHADIER A, BEZANNIER L,  BARRE-PIERREL S, MANCEAU A,  ABADIE A, DETOURNAY B.

    J Med Screen ; 2023;9691413231158932

  • Pharmaco-EpidĂ©miologie

    The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus.

    DE SEZE J, SUCHET L, MEKIES C, MANCHON E, LABAUGE P, GUENNOC AM, DEFER G, CLAVELOU P, CASTELNOVO G, BOURRE B, BENSA-KOSCHER C, AL KHEDR A, LE MAO J, VILLEMUR L, BOUEE S, LUCIANI L, VERMERSCH P.

    Neurol Ther ; 2023;12(2):351-369

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance data

    FAGNANI F, LAURENDEAU C, DE ZELICOURT M, MARSHALL J.

    Epilepsia Open ; 2022;7(4):633-644

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014-2017

    VERMERSCH P, SUCHET L, COLAMOARINO R, LAURENDEAU C, DETOURNAY B

    Mult Scler Relat Disord ; 2020;46:102521

  • Économie de la santĂ©

    Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.

    DETOURNAY B, DEBOUVERIE M, PEREIRA O, SEYER D, SOUDAN M, COUROUVE L, JHOMA K, EPSTEIN J, GUILLEMIN F.

    Mult Scler Relat Disord ; 2019;36:101396

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Migraine burden and costs in france: a nationwide claims database analysis of triptan users.

    DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.

    J Med Econ ; 2019;22(7):616-624

  • Économie de la santĂ©

    Multiple Source of Information to Characterize the Clinical, Therapeutic Management and Economic Burden of Patients with Multiple Sclerosis in France.

    EPSTEIN J, DETOURNAY B , GUILLEMIN F, DEBOUVERIE M, COUSIN M, TEHARD B, GAROT T, BITOUN L, SOUDANT M , DEPOORTERE PH, PAU D

    Value in Health ; 2017;20(9):a719

  • Économie de la santĂ©

    Effect of Multiple Sclerosis on Work Productivity

    DETOURNAY B, COUSIN M, GOURMELEN J, PAU D, PINGUET JM, TEHARD B, COZZONE D

    Value in Health ; 2017;20(9):a725

  • Économie de la santĂ©

    Effect of Multiple Sclerosis on Work Productivity

    DETOURNAY B, COUSIN M, GOURMELEN J, PAU D, PINGUET JM, TEHARD B, COZZONE D

    Value in Health ; 2017;20(9):a725

  • Économie de la santĂ©

    The Direct Cost of Patients With Multiple Sclerosis In France

    DETOURNAY B, COUSIN M, GOURMELEN J, L. BITOUN L, PAU D, COZZONE D, B. TEHARD B

    Value in Health ; 2017;20(9):a721

  • Économie de la santĂ©

    The Direct Cost of Patients With Multiple Sclerosis In France

    DETOURNAY B, COUSIN M, GOURMELEN J, L. BITOUN L, PAU D, COZZONE D, B. TEHARD B

    Value in Health ; 2017;20(9):a721